The induction of experimental vascular diseases by immunization with pathogenic autoantibodies

Clinical and Experimental Rheumatology

Volumn 18, Issue 2, 2000, Pages 257-261

  Krause, I ^a,b   Blank, M ^a,b   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

ANCA; Anti endothelial cell antibodies; Atherosclerosis; Goodpasture's syndrome; Vasculitis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULITIS; WEGENER GRANULOMATOSIS;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERIOSCLEROSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; IMMUNIZATION; VASCULAR DISEASES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034083995     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. GREENBERG AH: Antibodies and natural immunity. Biomed Pharmacother 1985; 39:4-6.
2. SHOENFELDY: Pathogenic natural autoantibodies. Isr J Med Sci 1993; 29: 142-5.
3. SHOENFELD Y, ISENBERG DA: The mosaic of autoimmunity. Immunol Today 1989;10:123-6.
4. TINCANI A, BALESTRIERI G, ALLEGRI F, et al.: Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin Exp Rheumatol 1993; 11: 129-34.
5. DANG H, OGAWA N, TAKEI M, LAZARIDIS K, TALAL N: Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. J Immunol 1993; 151: 7260-7.
6. ROMBACH E, STETLER DA, BROWN JC: Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in responses to immunization with either human or murine SLE anti-DNA antibodies. Autoimmunity 1992; 13: 291-302.
7. MENDLOVIC S, BROCKE S, SHOENFELD Y, et al.: Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 1988; 85: 2260-4.
8. BLANK M, KRUP M, MENDLOVIC S, et al.: The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 1990; 31: 45-52.
9. MENDLOVIC S, FRICKE H, SHOENFELD Y, MOZES E: The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Eur J Immunol 1989; 19: 729-34.
10. BAKIMER R, FISHMAN P, BLANK M, et al.: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558-63.
11. BLANK M, COHEN J, TODER V, SHOENFELD Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-73.
12. BLANK M, TOMER Y, STEIN M, et al.: Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 1995; 102:120-30.
13. BLANK M, CINES DB, AREPALLY G, et al.: Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: Generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin. Clin Exp Immunol 1997; 108: 333-9.
14. DAMIANOVICH M, GILBURD B, GEORGE J, et al.: Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model, J Immunol 1996; 156: 4946-51.
15. SHOENFELD Y: Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 1994; 8: 1296-301.
16. BLANK M, KRAUSE I, BEN BASSAT M, SHOENFELD Y: Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun 1992; 5: 495-509.
17. JERNE NK: Towards a network theory of the immune system. Ann Immunol Paris 1974; 125c: 373-89.
18. JERNE NK, ROLAND J, CAZENAVE PA: Recurrent idiotopes and internal images. EMBO J 1982; 1: 243-7.
19. COHEN J, BAKIMER R, BLANK M, VALESINI G, SHOENFELD Y: Pathogenic natural anti-cardiolipin antibodies: The experience from monoclonal gammopathy. Clin Exp Immunol 1994; 97: 181-6.
20. TOMER Y, GILBURD B, BLANK M, et al: Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum 1995; 38: 1375-81.
21. DAVIES DJ, MORAN JE, NIALL JF, RYAN GB: Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology ? Br Med J Clin Res Ed 1982; 285: 606.
22. KALLENBERG CG, BROUWER E, WEENING JJ, TERVAERT JW: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney lnt 1994; 46: 1-15.
23. HEERINGA P, BROUWER E, COHEN TERVAERT JW, WEENING JJ, KALLENBERG CG: Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney lnt 1998; 53: 253-63.
24. JENNETTE JC, FALK RJ: Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.
25. KETTRITZ R, YANG JJ, KINJOH K, JENNETTE JC, FALK RJ: Animal models in ANCA-vasculitis. Clin Exp Immunol 1995; 101 (Suppl. 1): 12-5.
26. BROUWER E, HUITEMA MG, KLOK PA, et al.: Antimyeloperoxidase-associated proliferative glomerulonephritis: An animal model. J Exp Med 1993; 177: 905-14.
27. YANG JJ, JENNETTE JC, FALK RJ: Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol 1994; 97: 466-73.
28. 2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut. Am J Pathol 1997; 151:131-40.
29. FALK RJ, JENNETTE JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 1997; 8: 314-22.
30. TOMER Y, BARAK V, GILBURD B, SHOENFELD Y: Cytokines in experimental autoimmune vasculitis: Evidence for a Th2 type response. Clin Exp Rheumatol 1999: 17; 521-6.
31. BOLTON WK: Goodpasture's syndrome. Kidney Int 1996; 50: 1753-66.
32. ABBATE M, KALLURI R, CORNA D, et al.: Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen. Kidney Int 1998;54:1550-61.
33. SHOENFELD Y, GILBURD B, HOJNIK M, et al.: Induction of Goodpasture antibodies to non-collagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation. Hum Antibodies Hybridomas 1995; 6: 122-8.
34. SHOENFELD Y: Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome. Isr J Med Sci 1996; 32:29-31.
35. MERONI PL, KHAMASHTA MA, YOUINOU P, SHOENFELD Y: Mosaic of anti-endothelial antibodies. Review of the First International Workshop on Anti-Endothelial Antibodies: Clinical and Pathological Significance (Milan, 9 November 1994). Lupus 1995; 4: 95-9.
36. ADLER Y, SALOZHIN K, LE TONQUEZE M, SHOENFELD Y, YOUINOU P: Anti-endothelial cell antibodies: A need for standardization. Lupus 1994; 3: 77-84.
37. YOUINOU P, MERONI PL, KHAMASHTA MA, SHOENFELD Y: A need for standardization of the anti-endothelial-cell antibody test. Immunol Today 1995; 16: 363-4.
38. ROSENBAUM J, POTTINGER BE, WOO P, et al.: Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450-6.
39. BODOLAY E, BOJAN F, SZEGEDI G, STENSZKY V, FARID NR: Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 1989; 20: 163-7.
40. DEL PAPA N, MERONI PL, BARCELLINI W, et al.: Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol 1992; 63: 267-74.
41. FERRARO G, MERONI PL, TINCANI A, et al.: Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 47-53.
42. CARVALHO D, SAVAGE CO, BLACK CM, PEARSON JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996; 97: 111-9.
43. SIMANTOV R, LASALA JM, LO SK, et al.: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-9.
44. DEL PAPA N, GUIDALI L, SIRONI M, et al.: Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-66.
45. DEL PAPA N, GUIDALI L, SALA A, et al.: Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-61.
46. GEORGE J, BLANK M, LEVY Y, et al.: Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97: 900-6.
47. LEVY Y. GILBURD B, GEORGE J, et al.: Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. Int Immunol 1998; 10: 861-8.
48. BLANK M, KRAUSE I, GOLDKORN T, et al.: Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999; 42: 1421-32.
49. ROSS R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-9.
50. WITZTUM JL: The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-5 (Review).
51. WICK G, SCHETT G, AMBERGER A, KLEINDIENST R, XU Q: Is atherosclerosis an immunologically mediated disease ? Immunol Today 1995; 16: 27-33.
52. LIBBY P, HANSSON GK: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 1991; 64: 5-15.
53. GEORGE J, HARATS D, GILBURD B, SHOENFELD Y: Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol Res 1996; 15: 315-22.
54. COOK PJ, LIP GY: Infectious agents and atherosclerotic vascular disease. QJM 1996; 89: 727-35.
55. JONSSON H, NIVEDO, STURFELT G: Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989; 68: 141-50.
56. JULIANO L, PRATICO D, FERRO D, et al.: Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood 1997; 90: 3931-5.
57. SHOENFELD Y, KARATS D, GEORGE J: Atherosclerosis and the antiphospholipid syndrome: A link unravelled? Lupus 1998; 7 (Suppl. 2): S140-3.
58. GEORGE J, AFEK A, GILBURD B, et al.: Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 1998; 98: 1108-15.
59. AFEK A, GEORGE J, SHOENFELD Y, et al.: Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice. Pathobiology 1999; 67: 19-25.
60. GEORGE J, AFEK A, GILBLURD B, et al.: Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997; 6: 723-9.
61. GEORGE J, SHOENFELD Y, AFEK A, et al.: Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 1999; 19: 505-10.